Provider Fact Sheet
Total Page:16
File Type:pdf, Size:1020Kb
Provider Fact Sheet Evaluation of exposed contacts: Exposure to Tuberculosis TB skin test by the Mantoux method (5 Individuals exposed to an adolescent or adult with TU PPD injected intradermally and read pulmonary or laryngeal tuberculosis are at high at 48 – 72 hours by a health care risk for infection with M. tuberculosis and professional) unless previously positive progression to tuberculosis disease (TB). Because progression to TB is most likely in the first two History and physical exam evaluating for years after infection, this group should be TB (symptoms of TB include cough in evaluated and treated aggressively. 70% of adults, fever (60%), weight loss, fatigue, chills etc. Hemoptysis is The following information regarding the source uncommon.) case is helpful: Chest radiograph The intimacy and duration of their contact. o if the patient had a prior positive TST Information regarding the level of contagion of the source case (patients o if the patient has a positive with long-standing symptoms, smear TST positive sputum and cavities on o if the patient has a negative radiograph are more likely to be TST and: contagious) is HIV infected Sensitivity of the source case TB isolate. < 5 years of age is immunocompromised has symptoms of active TB
Classification of Individuals Exposed to Active TB
* Young infants may not make a positive skin test – talk to a TB expert if the exposed is a young infant
Diagnosis TST Symptoms of TB Radiograph Treatment Class 1 TB < 5 mm None Normal if done Consider “window exposure INH” for 8-10 weeks – then repeat TST* Class 2 or latent > 5 mm None Normal Treat with 9 months of TB infection INH (LTBI) Class 4 old-scarred > 5 mm None (cultures Stable over three 4 mo INH/RIF TB negative if done) months 9 mo INH * Class 5 TB suspect May be Present in > 80% of Abnormal in Report to TB control; positive or adults with TB pulmonary TB four TB drugs after negative cultures
From Pediatric Tuberculosis: An Online Presentation by Ann Loeffler, MD. Produced by the Francis J. Curry National Tuberculosis Center.